Stock 2219 CHAOJU EYE CARE HOLDINGS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Chaoju Eye Care Holdings Limited

Equities

2219

KYG2047K1094

Delayed Hong Kong S.E.
Other stock markets
 01:09:01 2024-06-11 am EDT 		5-day change 1st Jan Change
3.6 HKD -0.55% Intraday chart for Chaoju Eye Care Holdings Limited +1.41% -18.55%
Jun. 06 Chaoju Eye Care Holdings Limited Approves Final Dividend for the Year Ended December 31, 2023 CI
Jun. 03 Chaoju Eye Care Unit Invests 150 Million Yuan in Bank of China’s Structured Deposits MT

Summary

  • From a short-term investment perspective, the company presents a deteriorated fundamental situation

Strengths

  • Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
  • Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
  • The group's high margin levels account for strong profits.
  • The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
  • The company's share price in relation to its net book value makes it look relatively cheap.
  • The company is one of the best yield companies with high dividend expectations.
  • Over the last twelve months, the sales forecast has been frequently revised upwards.
  • Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • The opinion of analysts covering the stock has improved over the past four months.
  • Considering the small differences between the analysts' various estimates, the group's business visibility is good.

Weaknesses

  • For the past year, analysts have significantly revised downwards their profit estimates.
  • For the last few months, analysts have been revising downwards their earnings forecast.
  • Over the past four months, analysts' average price target has been revised downwards significantly.
  • Over the past twelve months, analysts' opinions have been revised negatively.

Ratings chart - Surperformance

Sector: Healthcare Facilities & Services

1st Jan change Capi. Investor Rating ESG Refinitiv
CHAOJU EYE CARE HOLDINGS LIMITED Stock Chaoju Eye Care Holdings Limited
-18.55% 312M -
AIER EYE HOSPITAL GROUP CO., LTD. Stock Aier Eye Hospital Group Co., Ltd.
-25.47% 15.12B
B+
BANGKOK DUSIT MEDICAL SERVICES Stock Bangkok Dusit Medical Services
-3.60% 11.57B
B
APOLLO HOSPITALS ENTERPRISE LIMITED Stock Apollo Hospitals Enterprise Limited
+7.53% 10.43B
B+
ENCOMPASS HEALTH CORPORATION Stock Encompass Health Corporation
+28.84% 8.66B
B
RAMSAY HEALTH CARE LIMITED Stock Ramsay Health Care Limited
-7.07% 7.45B
A-
THE ENSIGN GROUP, INC. Stock The Ensign Group, Inc.
+6.42% 6.74B
B-
MOUWASAT MEDICAL SERVICES COMPANY Stock Mouwasat Medical Services Company
+8.59% 6.48B
D
DALLAH HEALTHCARE COMPANY Stock Dallah Healthcare Company
-2.79% 4.35B -
FORTIS HEALTHCARE LIMITED Stock Fortis Healthcare Limited
+11.34% 4.17B
B+
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
EV / Sales
-
Price to Book
Price to Free Cash Flow
-
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. 2219 Stock
  4. Ratings Chaoju Eye Care Holdings Limited